Darbufelone Mesilate

甲磺酸达布非隆

Report date: 2023/06/28 17:07:40
NME

Base Information

Drug NameDarbufelone Mesilate
Drug Alias Namedarbufelona甲磺酸达布非酮darbufelonum甲磺酸达布非龙Darbufelone mesylate +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitorsArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenaseCyclooxygenases
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesPfizer IncZhuhai United Laboratories Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesZhuhai United Laboratories Co Ltd
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A